Clinical Trial Update: The Effect of PHGG-rich Enteral Nutrition to on the Infection in Liver Transplant Recipients: A Prospective, Double-blind, Randomized Controlled Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial investigating PHGG-rich enteral nutrition for reducing infections in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections in Liver Transplant Recipients
• Liver Transplantation Complications

Drugs mentioned

• PHGG-rich enteral nutrition

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Infections | Phase 4 | Status: UNKNOWN